Abstract
Mucous epithelia and their glands represent vital surfaces of the body which are topologically in direct contact and communicate with the environment. These highly specialized epithelia are protected by several lines of defence, such as mucous gels, regeneration and repair mechanisms, and acute inflammatory processes. Pathologically, chronic inflammation is associated with cancer. There are two different regeneration and repair mechanisms of mucous epithelia known which also cover different time scales. First, rapid repair of superficial lesions via cell migration - a process called restitution - starts within minutes. Second, continuous regeneration via differentiation and proliferation of stem and progenitor cells is responsible for self-renewal within days to months. This article reviews molecular mechanisms responsible for the regeneration of various mucous epithelia with a special emphasis on the complex situation in the gastric mucosa and its glands. For example, the two gross types of gastric units, i.e., the fundic and the antral types, respectively, differ largely by their histology, regeneration rates and regeneration profiles. Currently, a rough picture is emerging on the molecular mechanisms behind including the characterization of different somatic stem cell types and stem cell signaling pathways. Furthermore, dysregulated regeneration is well known now as a cause of various metaplasias (reversible remodeling of epithelia) and cancer, with chronic inflammation playing a key role. Understanding the molecular mechanisms of regeneration and their dysregulation is essential for the development of new strategies for cancer prevention and therapy and it will also promote the emerging field of regenerative medicine and tissue engineering.
Keywords: Gastric mucosa, regenerative medicine, stem cells, regeneration, gastric cancer, intestinal metaplasia, SPEM, trefoil factors
Current Medicinal Chemistry
Title: Regeneration of the Gastric Mucosa and its Glands from Stem Cells
Volume: 15 Issue: 29
Author(s): Werner Hoffmann
Affiliation:
Keywords: Gastric mucosa, regenerative medicine, stem cells, regeneration, gastric cancer, intestinal metaplasia, SPEM, trefoil factors
Abstract: Mucous epithelia and their glands represent vital surfaces of the body which are topologically in direct contact and communicate with the environment. These highly specialized epithelia are protected by several lines of defence, such as mucous gels, regeneration and repair mechanisms, and acute inflammatory processes. Pathologically, chronic inflammation is associated with cancer. There are two different regeneration and repair mechanisms of mucous epithelia known which also cover different time scales. First, rapid repair of superficial lesions via cell migration - a process called restitution - starts within minutes. Second, continuous regeneration via differentiation and proliferation of stem and progenitor cells is responsible for self-renewal within days to months. This article reviews molecular mechanisms responsible for the regeneration of various mucous epithelia with a special emphasis on the complex situation in the gastric mucosa and its glands. For example, the two gross types of gastric units, i.e., the fundic and the antral types, respectively, differ largely by their histology, regeneration rates and regeneration profiles. Currently, a rough picture is emerging on the molecular mechanisms behind including the characterization of different somatic stem cell types and stem cell signaling pathways. Furthermore, dysregulated regeneration is well known now as a cause of various metaplasias (reversible remodeling of epithelia) and cancer, with chronic inflammation playing a key role. Understanding the molecular mechanisms of regeneration and their dysregulation is essential for the development of new strategies for cancer prevention and therapy and it will also promote the emerging field of regenerative medicine and tissue engineering.
Export Options
About this article
Cite this article as:
Hoffmann Werner, Regeneration of the Gastric Mucosa and its Glands from Stem Cells, Current Medicinal Chemistry 2008; 15 (29) . https://dx.doi.org/10.2174/092986708786848587
DOI https://dx.doi.org/10.2174/092986708786848587 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness
Anti-Cancer Agents in Medicinal Chemistry Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Targeted α-Particle Therapy: A Clinical Overview
Current Radiopharmaceuticals Microwave-assisted Cycloaddition Reactions in Carbo- and Heterocyclic Chemistry
Current Organic Chemistry Pluripotent Stem Cells for Livestock Health and Production
Current Stem Cell Research & Therapy Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry Modelling and Measuring Redox Cycling and Cytotoxicity of Quinones
Drug Metabolism Letters Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk
Current Drug Safety c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Smart Drug Release Systems Based on Stimuli-Responsive Polymers
Mini-Reviews in Medicinal Chemistry KRAB-Zinc Finger Proteins: A Repressor Family Displaying Multiple Biological Functions
Current Genomics The Role of Anaphylatoxins C3a and C5a in Regulating Innate and Adaptive Immune Responses
Inflammation & Allergy - Drug Targets (Discontinued) The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Intriguing Classes of Acridine Derivatives as DNA-binding Antitumour Agents: From Pyrimido[5,6,1-de]acridines to Bis(acridine-4-carboxamides)
Medicinal Chemistry Reviews - Online (Discontinued) Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells
Current Pharmaceutical Design Omacetaxine as an Anticancer Therapeutic: What is Old is New Again
Current Pharmaceutical Design Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry